Algorithme Pharma announces key clinic appointments

Laval, Friday, April 8, 2011 – Chris Perkin, President and Chief Executive Officer, is pleased to announce the appointments of Ingrid Holmes as Senior Director - Clinical Operations , Matthew Logan as Associate Director - Clinical Operations and Pasquale (Patrick) Omobono as Senior Manager - Clinical Operations.

Laval, Friday, April 8, 2011 – Chris Perkin, President and Chief Executive Officer, is pleased to announce the appointments of Ingrid Holmes as Senior Director - Clinical Operations , Matthew Logan as Associate Director - Clinical Operations and Pasquale (Patrick) Omobono as Senior Manager - Clinical Operations.

These key appointments further reinforce Algorithme Pharma’s commitment to expand its business offering through its clinical capabilities into new areas of focus.

Ingrid Holmes, our new Senior Director - Clinical Operations, has over 16 years industry experience and worked for an international multi-site CRO in different roles from Clinical Study Manager up to Global Director of Clinical Operations.

Matthew Logan, our new Associate Director - Clinical Operations, has over 13 years experience in the industry. He started as a Phlebotomist and progressed through increasing management responsibilities to Manager - Clinical Operations.

Pasquale (Patrick) Omobono joins us as Senior Manager - Clinical Operations and also has over 13 years experience in the clinical research field. He started as a Technician/Training Specialist, progressing to Study Manager for 7 years and then finally Clinical Conduct Manager.

These additional team members bring with them extensive hands-on experience in different elements of study conduct and help us better position ourselves for business growth.

About Algorithme Pharma
As a major global player in Clinical Research and Bioanalysis, Algorithme Pharma provides a wide range of services for early stage clinical development studies to the pharmaceutical, and biotechnology industries. In addition to its multi-unit clinical facilities in Canada and the United Kingdom, Algorithme Pharma offers different services including protocol designs, CTD/ICH clinical reports, data management, biostatistics, quality assurance and regulatory affairs. Successfully audited by the US FDA, Canada TPD, Brazil ANVISA, France AFSSAPS, UK MHRA and Austria AGES regulatory authorities, Algorithme Pharma conducts over 275 clinical trials per year.

Information:
Mr. Chris Perkin
450) 973-6077
contact@algopharm.com
www.algopharm.com